EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Rocatinlimab Significantly Improves Clinical Signs and Symptoms of Moderate-to-Severe Atopic Dermatitis by Specifically Reducing OX40R+ T-Cell Population Without Signs of Immunosuppression

Friday 13 Jun, 09:24 AM - 09:36 AM Glasgow, United Kingdom